Literature DB >> 18709642

Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans.

Jeffrey S Chang1, Margaret R Wrensch, Helen M Hansen, Jennette D Sison, Melinda C Aldrich, Charles P Quesenberry, Michael F Seldin, Karl T Kelsey, Rick A Kittles, Gabriel Silva, John K Wiencke.   

Abstract

Few studies on the association between nucleotide excision repair (NER) variants and lung cancer risk have included Latinos and African Americans. We examine variants in 6 NER genes (ERCC2, ERCC4, ERCC5, LIG1, RAD23B and XPC) in association with primary lung cancer risk among 113 Latino and 255 African American subjects newly diagnosed with primary lung cancer from 1998 to 2003 in the San Francisco Bay Area and 579 healthy controls (299 Latinos and 280 African Americans). Individual single nucleotide polymorphism and haplotype analyses, multifactor dimensionality reduction (MDR) and principal components analysis (PCA) were performed to assess the association between 6 genes in the NER pathway and lung cancer risk. Among Latinos, ERCC2 haplotype CGA (rs238406, rs11878644, rs6966) was associated with reduced lung cancer risk [odds ratio (OR) of 0.65 and 95% confidence interval (CI): 0.44-0.97], especially among nonsmokers (OR = 0.29; 95% CI: 0.12-0.67). From MDR analysis, in Latinos, smoking and 3 SNPs (ERCC2 rs171140, ERCC5 rs17655 and LIG1 rs20581) together had a prediction accuracy of 67.4% (p = 0.001) for lung cancer. Among African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88). Our study suggests different elements of the NER pathway may be important in the different ethnic groups resulting either from different linkage relationship, genetic backgrounds and/or exposure histories. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18709642      PMCID: PMC2734972          DOI: 10.1002/ijc.23801

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  69 in total

1.  Genetic polymorphisms in DNA repair genes and risk of lung cancer.

Authors:  D Butkiewicz; M Rusin; L Enewold; P G Shields; M Chorazy; C C Harris
Journal:  Carcinogenesis       Date:  2001-04       Impact factor: 4.944

2.  Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer.

Authors:  Jae Yong Park; Su Yeon Lee; Hyo-Sung Jeon; Sun Ha Park; Nack Chun Bae; Eung Bae Lee; Sung Ick Cha; Jae-Ho Park; Sin Kam; In-San Kim; Tae Hoon Jung
Journal:  Lung Cancer       Date:  2002-04       Impact factor: 5.705

3.  No association between the XPD (Lys751G1n) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk.

Authors:  G L David-Beabes; R M Lunn; S J London
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-08       Impact factor: 4.254

4.  Polymorphism of DNA ligase I and risk of lung cancer--a case-control analysis.

Authors:  Hongbing Shen; Margaret R Spitz; Yawei Qiao; Yuxin Zheng; Waun K Hong; Qingyi Wei
Journal:  Lung Cancer       Date:  2002-06       Impact factor: 5.705

5.  The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk.

Authors:  Sai-Mei Hou; Susann Fält; Sabrina Angelini; Ke Yang; Fredrik Nyberg; Bo Lambert; Kari Hemminki
Journal:  Carcinogenesis       Date:  2002-04       Impact factor: 4.944

Review 6.  How nucleotide excision repair protects against cancer.

Authors:  E C Friedberg
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

7.  Associations between ERCC2 polymorphisms and gliomas.

Authors:  M Caggana; J Kilgallen; J M Conroy; J K Wiencke; K T Kelsey; R Miike; P Chen; M R Wrensch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-04       Impact factor: 4.254

8.  Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.

Authors:  M R Spitz; X Wu; Y Wang; L E Wang; S Shete; C I Amos; Z Guo; L Lei; H Mohrenweiser; Q Wei
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

9.  Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer.

Authors:  Wei Zhou; Geoffrey Liu; David P Miller; Sally W Thurston; Li Lian Xu; John C Wain; Thomas J Lynch; Li Su; David C Christiani
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

10.  Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer.

Authors:  M D Ritchie; L W Hahn; N Roodi; L R Bailey; W D Dupont; F F Parl; J H Moore
Journal:  Am J Hum Genet       Date:  2001-06-11       Impact factor: 11.025

View more
  40 in total

1.  Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers.

Authors:  Lori C Sakoda; Melissa M Loomis; Jennifer A Doherty; Liberto Julianto; Matt J Barnett; Marian L Neuhouser; Mark D Thornquist; Noel S Weiss; Gary E Goodman; Chu Chen
Journal:  Int J Mol Epidemiol Genet       Date:  2012-02-05

Review 2.  A review of cancer in U.S. Hispanic populations.

Authors:  Robert W Haile; Esther M John; A Joan Levine; Victoria K Cortessis; Jennifer B Unger; Melissa Gonzales; Elad Ziv; Patricia Thompson; Donna Spruijt-Metz; Katherine L Tucker; Jonine L Bernstein; Thomas E Rohan; Gloria Y F Ho; Melissa L Bondy; Maria Elena Martinez; Linda Cook; Mariana C Stern; Marcia Cruz Correa; Jonelle Wright; Seth J Schwartz; Lourdes Baezconde-Garbanati; Victoria Blinder; Patricia Miranda; Richard Hayes; George Friedman-Jiménez; Kristine R Monroe; Christopher A Haiman; Brian E Henderson; Duncan C Thomas; Paolo Boffetta
Journal:  Cancer Prev Res (Phila)       Date:  2012-02

3.  Structures of Rpn1 T1:Rad23 and hRpn13:hPLIC2 Reveal Distinct Binding Mechanisms between Substrate Receptors and Shuttle Factors of the Proteasome.

Authors:  Xiang Chen; Leah Randles; Ke Shi; Sergey G Tarasov; Hideki Aihara; Kylie J Walters
Journal:  Structure       Date:  2016-07-07       Impact factor: 5.006

4.  A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility.

Authors:  Chuan Liu; Qinghua Yin; Jianbing Hu; Lian Li; Yingyi Zhang; Yajie Wang
Journal:  Tumour Biol       Date:  2013-02-06

5.  DNA Repair Gene Polymorphisms in the Nucleotide Excision Repair Pathway and Lung Cancer Risk: A Meta-analysis.

Authors:  Chao-Rong Mei; Meng Luo; Hong-Mei Li; Wen-Jun Deng; Qing-Hua Zhou
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

6.  Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations.

Authors:  Jing He; Li-Xin Qiu; Meng-Yun Wang; Rui-Xi Hua; Ruo-Xin Zhang; Hong-Ping Yu; Ya-Nong Wang; Meng-Hong Sun; Xiao-Yan Zhou; Ya-Jun Yang; Jiu-Cun Wang; Li Jin; Qing-Yi Wei; Jin Li
Journal:  Hum Genet       Date:  2012-02-28       Impact factor: 4.132

7.  Comprehensive assessment of the association between XPD rs13181 polymorphism and lung cancer risk.

Authors:  Hai-Ying Wu; Ling-Yu Ding
Journal:  Tumour Biol       Date:  2014-05-21

8.  Note of clarification of data in the meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility.

Authors:  Qiang Zhang; Ganzhong Wei; Xiaoming Wu; Ying Luo
Journal:  Tumour Biol       Date:  2014-07-02

9.  Genetic association between ERCC5 rs17655 polymorphism and lung cancer risk: evidence based on a meta-analysis.

Authors:  Yujia Liang; Jun Deng; Ying Xiong; Songping Wang; Wei Xiong
Journal:  Tumour Biol       Date:  2014-03-05

10.  Lung cancer risk and genetic polymorphisms in DNA repair pathways: a meta-analysis.

Authors:  Chikako Kiyohara; Koichi Takayama; Yoichi Nakanishi
Journal:  J Nucleic Acids       Date:  2010-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.